UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:June 17,
AcelRX Pharmaceuticals (NASDAQ:ACRX)
Historical Stock Chart
From Sep 2024 to Oct 2024 Click Here for more AcelRX Pharmaceuticals Charts.
AcelRX Pharmaceuticals (NASDAQ:ACRX)
Historical Stock Chart
From Oct 2023 to Oct 2024 Click Here for more AcelRX Pharmaceuticals Charts.

Acelrx Pharmaceuticals Inc News

Form 4 - Statement of changes in beneficial ownership of securities
Monday 24 June 2024 (4 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Monday 24 June 2024 (4 months ago) • Edgar (US Regulatory)
Form ARS - Annual Report to Security Holders
Monday 29 April 2024 (5 months ago) • Edgar (US Regulatory)
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Monday 29 April 2024 (5 months ago) • Edgar (US Regulatory)
Form DEF 14A - Other definitive proxy statements
Monday 29 April 2024 (5 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Friday 19 April 2024 (6 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Thursday 21 March 2024 (7 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Friday 15 March 2024 (7 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 12 March 2024 (7 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Tuesday 9 January 2024 (9 months ago) • Edgar (US Regulatory)
AcelRx Announces Rebranding With Name Change to Talphera, Inc.
Tuesday 9 January 2024 (9 months ago) • PR Newswire (US)
Form 4 - Statement of changes in beneficial ownership of securities
Thursday 14 December 2023 (10 months ago) • Edgar (US Regulatory)

More Acelrx Pharmaceuticals Inc News Articles